Ultime notizie per Keurig Dr Pepper (NASDAQ:KDP) Azioni

Keurig Dr Pepper

Dr Pepper Snapple Group

Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. The company controls production and route to market for its own brands through in-house manufacturing plants and distribution infrastructure and leverages these facilities to manufacture and distribute for third-party coffee and beverage brands via licensing and partnership agreements. US and Canada make up 95% of revenues, with the rest from Mexico.

Keurig Dr Pepper Inc

Barclays analyst Raimo Lenschow maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Equal-Weight and raises the price target from $142 to $172.

News

Price Target

Analyst Ratings

SNOW

Barclays Maintains Equal-Weight on Snowflake, Raises Price Target to $172

FAA Administrator Says He Plans To Soon Visit Boeing In Seattle To Meet With CEO

Deep-pocketed investors have adopted a bullish approach towards Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in TSM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 15 extraordinary options activities for Taiwan Semiconductor. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 53% leaning bullish and 33% bearish. Among these notable options, 3 are puts, totaling $127,002, and 12 are calls, amounting to $1,082,394.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $170.0 and $220.0 for Taiwan Semiconductor, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Taiwan Semiconductor's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Taiwan Semiconductor's substantial trades, within a strike price spectrum from $170.0 to $220.0 over the preceding 30 days.
<h3>Taiwan Semiconductor Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732202321_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$15.75</td>
<td>$15.45</td>
<td>$15.73</td>
<td>$190.00</td>
<td>$314.6K</td>
<td>2.4K</td>
<td align="right">374</td>
</tr>
<tr>
<td>TSM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$27.1</td>
<td>$26.4</td>
<td>$26.96</td>
<td>$185.00</td>
<td>$134.8K</td>
<td>1.0K</td>
<td align="right">50</td>
</tr>
<tr>
<td>TSM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$26.4</td>
<td>$25.6</td>
<td>$26.07</td>
<td>$185.00</td>
<td>$130.3K</td>
<td>1.0K</td>
<td align="right">100</td>
</tr>
<tr>
<td>TSM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$5.55</td>
<td>$5.25</td>
<td>$5.55</td>
<td>$187.50</td>
<td>$111.0K</td>
<td>12.7K</td>
<td align="right">201</td>
</tr>
<tr>
<td>TSM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$5.25</td>
<td>$5.2</td>
<td>$5.25</td>
<td>$187.50</td>
<td>$68.2K</td>
<td>12.7K</td>
<td align="right">364</td>
</tr>
</tbody>
</table>

<h3>About Taiwan Semiconductor</h3>
Taiwan Semiconductor Manufacturing Co. is the world's largest dedicated chip foundry, with over 60% market share. TSMC was founded in 1987 as a joint venture of Philips, the government of Taiwan, and private investors. It went public as an ADR in the us in 1997. TSMC's scale and high-quality technology allow the firm to generate solid operating margins, even in the highly competitive foundry business. Furthermore, the shift to the fabless business model has created tailwinds for TSMC. The foundry leader has an illustrious customer base, including Apple, AMD, and Nvidia, that looks to apply cutting-edge process technologies to its semiconductor designs. TSMC employs more than 73,000 people.
In light of the recent options history for Taiwan Semiconductor, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Taiwan Semiconductor Standing Right Now?</h3>
<ul>
<li>With a trading volume of 4,231,883, the price of TSM is up by 0.23%, reaching $188.8.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 56 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Taiwan Semiconductor</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $227.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Taiwan Semiconductor, targeting a price of $215. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Taiwan Semiconductor with a target price of $240. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Taiwan Semiconductor options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Smart Money Is Betting Big In TSM Options

Financial giants have made a conspicuous bullish move on Dell Technologies. Our analysis of options history for Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) revealed 12 unusual trades.
Delving into the details, we found 66% of traders were bullish, while 8% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $107,308, and 9 were calls, valued at $515,995.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $120.0 to $150.0 for Dell Technologies over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Dell Technologies's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Dell Technologies's whale activity within a strike price range from $120.0 to $150.0 in the last 30 days. 
<h3>Dell Technologies Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732202316_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DELL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$4.55</td>
<td>$4.5</td>
<td>$4.5</td>
<td>$150.00</td>
<td>$225.0K</td>
<td>6.9K</td>
<td>1.0K</td>
</tr>
<tr>
<td>DELL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$10.95</td>
<td>$10.6</td>
<td>$10.95</td>
<td>$145.00</td>
<td>$60.2K</td>
<td>383</td>
<td>0</td>
</tr>
<tr>
<td>DELL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/22/24</td>
<td>$1.99</td>
<td>$1.79</td>
<td>$1.79</td>
<td>$135.00</td>
<td>$47.6K</td>
<td>1.9K</td>
<td>502</td>
</tr>
<tr>
<td>DELL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$21.1</td>
<td>$21.05</td>
<td>$21.1</td>
<td>$120.00</td>
<td>$42.2K</td>
<td>3.2K</td>
<td>21</td>
</tr>
<tr>
<td>DELL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$2.79</td>
<td>$2.78</td>
<td>$2.79</td>
<td>$150.00</td>
<td>$41.8K</td>
<td>2.3K</td>
<td>167</td>
</tr>
</tbody>
</table>

<h3>About Dell Technologies</h3>
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It is focused on premium and commercial personal computers and enterprise on-premises data center hardware. It holds top-three market shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners, and also relies heavily on channel partners to fulfill its sales.
<h3>Present Market Standing of Dell Technologies</h3>
<ul>
<li>With a volume of 1,188,427, the price of DELL is up 1.28% at $135.67. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 5 days.</li>
</ul>
<h3>Professional Analyst Ratings for Dell Technologies</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $154.66666666666666.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on Dell Technologies, maintaining a target price of $154. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Dell Technologies, which currently sits at a price target of $160. 
&#x2A; An analyst from Evercore ISI Group downgraded its action to Outperform with a price target of $150. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Dell Technologies, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

DELL

Dell Technologies Unusual Options Activity For November 21

Whales with a lot of money to spend have taken a noticeably bullish stance on Oracle.
Looking at options history for Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) we detected 31 trades.
If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and 35% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $1,437,766 and 28, calls, for a total amount of $1,238,765.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $160.0 to $220.0 for Oracle over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Oracle's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Oracle's substantial trades, within a strike price spectrum from $160.0 to $220.0 over the preceding 30 days.
<h3>Oracle 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732202310_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ORCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.57</td>
<td>$1.39</td>
<td>$1.4</td>
<td>$160.00</td>
<td>$1.2M</td>
<td>1.9K</td>
<td>10.0K</td>
</tr>
<tr>
<td>ORCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.4</td>
<td>$1.39</td>
<td>$1.4</td>
<td>$160.00</td>
<td>$166.9K</td>
<td>1.9K</td>
<td>1.1K</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$1.47</td>
<td>$1.2</td>
<td>$1.4</td>
<td>$202.50</td>
<td>$70.0K</td>
<td>3</td>
<td>2.0K</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$1.55</td>
<td>$1.09</td>
<td>$1.4</td>
<td>$202.50</td>
<td>$70.0K</td>
<td>3</td>
<td>1.5K</td>
</tr>
<tr>
<td>ORCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$1.44</td>
<td>$1.05</td>
<td>$1.4</td>
<td>$202.50</td>
<td>$70.0K</td>
<td>3</td>
<td>500</td>
</tr>
</tbody>
</table>

<h3>About Oracle</h3>
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Having examined the options trading patterns of Oracle, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Oracle</h3>
<ul>
<li>Trading volume stands at 976,741, with ORCL's price up by 0.53%, positioned at $191.76.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 18 days.</li>
</ul>
<h3>Professional Analyst Ratings for Oracle</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $182.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from RBC Capital downgraded its action to Sector Perform with a price target of $165. 
&#x2A; An analyst from Keybanc persists with their Overweight rating on Oracle, maintaining a target price of $200. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Oracle, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

ORCL

Smart Money Is Betting Big In ORCL Options

RBC Capital analyst Sabahat Khan maintains Jacobs Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) with a Outperform and lowers the price target from $167 to $152.

RBC Capital Maintains Outperform on Jacobs Solutions, Lowers Price Target to $152

Barclays analyst Alex Scott maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Underweight and raises the price target from $278 to $302.

Barclays Maintains Underweight on Willis Towers Watson, Raises Price Target to $302

On Thursday, Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) raised its mid-term sales guidance, increasing its compound annual growth rate (CAGR) target to 6% from 5% for 2023-2028.
The upgrade reflects performance from current growth drivers and anticipated launches, many of which are expected to retain U.S. exclusivity into the 2030s.
The <a target="_blank" href="https://www.novartis.com/news/media-releases/novartis-upgrades-mid-term-guidance-and-highlights-deep-pipeline-core-therapeutic-areas-drive-long-term-growth" rel="noreferrer noopener">updated</a> forecast, announced ahead of the company's Meet Novartis Management event in London, underscores its confidence in sustained momentum.
Novartis has outlined its projections for 2024-2029, maintaining a 5% CAGR target with 2024 as the base year.
The company remains on track to achieve a core operating income margin of over 40% by 2027, supported by continued sales growth and productivity enhancements.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41634528/positive-outlook-for-novartis-as-company-capitalizes-on-growing-treatment-opportuni" rel="noreferrer noopener">Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights</a>
The company said the business is gaining strong momentum, with eight marketed brands expected to generate $3 billion to $8 billion at peak sales.
CEO Vas Narasimhan noted increased peak sales estimates for flagship drugs, including Cosentyx, Kisqali, Kesimpta, Pluvicto, and Leqvio, alongside 15 pivotal submission-enabling readouts in the pipeline.
He highlighted the company's long-term strategy, identifying more than 30 promising pipeline assets poised to rejuvenate its portfolio and sustain mid-single-digit growth beyond 2029.
Over the past two years, Novartis has executed more than 30 deals targeting exploratory and preclinical stages. Recent acquisitions, such as Kate Therapeutics and a collaboration with Ratio Therapeutics, bolster its radioligand and gene therapy pipelines, expanding opportunities in neuromuscular and radiotherapeutic advancements.
In October, Novartis reported third-quarter sales of $12.823 billion, up 9% (+10% on constant currency), beating the consensus of $12.76 billion. Volume contributed 12 percentage <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41598312/novartis-q3-earnings-beats-expectations-on-strong-sales-from-key-drugs-lifts-2024-outlook" rel="noreferrer noopener">points to growth</a>.
The company said, "All key growth drivers contributed to the momentum. We achieved important indications expansions for&nbsp;Kisqali&nbsp;in early breast cancer and&nbsp;Fabhalta&nbsp;in IgA nephropathy&#8230;"
Novartis has <a target="_blank" href="https://www.novartis.com/stories/addressing-unmet-needs-inherited-neuromuscular-diseases" rel="noreferrer noopener">acquired</a> Kate Therapeutics to enhance and strengthen its portfolio of gene therapies.
Kate Therapeutics is a San Diego-based, preclinical-stage biotechnology company focused on developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined neuromuscular diseases.&nbsp;
The transaction value is up to $1.1 billion, comprising an upfront payment and potential additional milestone payments.
Kate Therapeutics' primary programs include preclinical candidates for Duchenne muscular dystrophy, facioscapulohumeral dystrophy, and myotonic dystrophy type 1.
Price Action: NVS stock is up 0.24% at $103.34 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/11/42098042/carlyle-sells-quidelortho-shares-analyst-sees-overhang-lifted" target="_blank" rel="noreferrer noopener">Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted</a></li>
</ul>
Photo by Taljat David via Shutterstock

Biotech

Large Cap

Guidance

Eurozone

Health Care

General

Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline

BMO Capital analyst Keith Bachman maintains Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) with a Outperform and raises the price target from $390 to $425.

PANW

BMO Capital Maintains Outperform on Palo Alto Networks, Raises Price Target to $425

Warren Buffett is a master of making money – and Coca-Cola is <a href="https://www.benzinga.com/startups/24/11/42011977/99-billion-bet-warren-buffett-invests-heavily-in-2-stocks-expected-to-jump-19-and-20-wall-street-analysts-predict">one of his biggest cash cows</a>. In 2024, Berkshire Hathaway, Buffett's investment behemoth, is set to rake in $776 million in Coca-Cola dividends alone.&nbsp;
Don't Miss:
<ul>
<li>This rooftop wind turbine is taking on a market projected to reach over $900 billion by 2032 —<a href="https://www.benzinga.com/money/halcium"> With already over 40,000 users signing up to purchase, here's a chance to be an early investor today!</a></li>
<li>This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai-2"> here's how there's a limited time opportunity to invest at $1,000 for only $0.50/share before it closes tonight.</a></li>
</ul>
That's right: $776 million for holding 400 million shares. According to Moneywise, this massive payout comes from Coca-Cola upping its quarterly dividend to 48.5 cents per share. If you're doing the math, that's $0.485 x 4 x 400,000,000. It&#8217;s not a bad haul for simply sitting on a mountain of Coke stock.
Buffett's love for Coca-Cola isn't just financial – it's personal. The 94-year-old billionaire famously drinks five cans daily and gets roughly 25% of his daily calories from the fizzy stuff. In a 2015 Fortune interview, he admitted, "If I eat 2,700 calories daily, a quarter of that is Coca-Cola. I drink at least five 12-ounce servings. I do it every day."&nbsp;
However, despite being Coca-Cola's largest shareholder and perhaps its most dedicated fan, Buffett doesn't get his favorite beverage for free. As revealed in the 2017 HBO documentary Becoming Warren Buffett, his wife Astrid even goes out of her way to buy the soda on sale. According to Buffett's daughter, Susie, her dad doesn't have room to stockpile the soda, but her mother bought it in bulk for the best price when she was alive.&nbsp;
Trending: ‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a>
Susie also revealed her famously frugal father's second wife, Astrid, also likes to get a deal. "Astrid is more likely to try to find out where it's on sale and buy it on sale."&nbsp;
While it may seem like Buffett has been a Coca-Cola lover forever, he once only drank its rival. <a href="https://www.benzinga.com/personal-finance/24/10/41198368/warren-buffetts-son-who-famously-cashed-in-his-90-000-inheritance-at-19-spends-millions-in-buffe">His son</a>, Howard, even called him "Pepsi Warren." He reportedly drank Pepsi for nearly 50 years before switching brands in the 1980s.&nbsp;
Buffett's switch from Pepsi to Coca-Cola reportedly had to do with his neighbor, Don Keough, a coffee salesperson in Omaha in the 1960s. According to Glen Arnold in The Deals of Warren Buffett Volume 2, Buffett once knocked on Keough's door with a pitch: "If you give me $10,000, I might be able to do something with it." Keough wasn't sold. "I didn't have it, but I could've borrowed it from my father. But can you imagine giving $10,000 to a guy who doesn't get up and go to work in the morning?" he later said. Keough passed on the offer, which Arnold estimated could've grown to $93 million by 2018.
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Years later, Keough climbed the corporate ladder at Coca-Cola, becoming its president and COO in the 1980s. Keough seized the moment when he read in a magazine that Buffett was hooked on Pepsi Cherry. He sent his old neighbor some Cherry Coke samples, calling it the "<a href="https://www.benzinga.com/general/24/02/37240748/warren-buffett-drinks-5-cans-of-coke-per-day-at-93-years-old-but-he-was-a-dedicated-pepsi-drinker-fo">nectar of the gods</a>." Buffett was hooked. In 1986, he even told Berkshire Hathaway shareholders that Cherry Coke was now the official drink of their annual meeting, cementing his switch – and his eventual investment – in Coca-Cola.
Buffett&#8217;s 400 million shares of Coca-Cola stock represent a massive portion of his investment portfolio, worth over $25 billion at current market prices. But this investment is more than just numbers – it's a perfect example of Buffett's <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">long-term approach to investing</a> and his connection to the brand, even if he does have to buy it on sale.&nbsp;
Read Next:
<ul>
<li>With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai-2">Be an early investor with just $1,000 for only $0.50/share today before the offer closes in less than 24 hours</a>!</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">You can still get 4,000 of its pre-IPO shares for with $1,000 for just $0.25/share</a></li>
</ul>

Warren Buffett Is Set To Collect $776 Million In Coca-Cola Dividends – But Daughter Says His Wife Buys Him The Soda 'On Sale'

BMO Capital analyst Kelly Bania maintains Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) with a Market Perform and lowers the price target from $160 to $120.

BMO Capital Maintains Market Perform on Target, Lowers Price Target to $120

ZenaTech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) disclosed on Wednesday that it signed the appropriate partner&nbsp;agreements for its supply chain to sell its ZenaDrone 1000 AI drone<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42109018/zenatech-signs-blue-uas-and-ndaa-compliant-supply-chain-partners-to-sell-to-us-defense-branches-an" rel="noreferrer noopener"> solutions to US defense branches and NATO forces</a>.
The company recently participated in a Taiwan Trade Mission organized by the Arizona Commerce Authority (ACA) that directly resulted in these partnerships.
ZenaTech confirmed that all electrical components and the supply chain for its ZenaDrone 1000 will comply with the U.S. National Defense Authorization Act (NDAA) standards.
The company previously completed successful paid trials with the U.S. Air Force and U.S. Naval Research, utilizing its drones for transporting critical cargo, such as blood, in field operations.
NDAA compliance involves adhering to the provisions of the National Defense Authorization Act, which sets the annual budget and expenditure guidelines for the U.S. Department of Defense (DoD) while addressing cybersecurity concerns.
To be NDAA compliant, products must not be sourced from a list of prohibited Chinese manufacturers, covering components such as chipsets, cameras, and displays.
The Blue UAS program is a government-approved supplier list for drone companies seeking to do business with the U.S. DoD. Suppliers must meet strict NDAA cybersecurity and supply chain sourcing standards.
The Green UAS program offers a similar process but with a more streamlined approach and without restrictions on the country of origin for manufacturing.
CEO Shaun Passley, said, &#8220;Our strategic relationship with the Arizona Commerce Authority has resulted in these important NDAA-compliant partners needed in order to qualify for the Blue UAS list. The next step is to complete the Green UAS list process, then we will be ready for the Blue UAS certification to be able to execute our plans to do more business with military organizations in the US, NATO and beyond.&#8221;
Price Action: ZENA shares are up 0.33% at $1.525 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42111372" target="_blank" rel="noreferrer noopener">Dan Ives Predicts Nvidia&#8217;s Blackwell Chips Are Heading For &#8216;Massive Demand Trajectory&#8217; As Jensen Huang Says &#8216;LeBron Of Chip Releases&#8217; To Surpass Hopper GPU Shipments</a></li>
</ul>

Equities

Contracts

Small Cap

Movers

ZENA

ZenaTech Secures Key Supply Chain Deals For ZenaDrone 1000 AI Drone Solutions: Details

RBC Capital analyst Matthew Hedberg reiterates N-able (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NABL#NYSE">NABL</a>) with a Outperform and maintains $15 price target.

Reiteration

NABL

RBC Capital Reiterates Outperform on N-able, Maintains $15 Price Target

Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>) co-founder Charles Hoskinson on Thursday named Coinbase Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) CEO Brian Armstrong for a potential crypto position at the White House, citing his unique position to bridge the gap between the digital asset <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42091821/could-donald-trumps-potential-treasury-secretary-be-out-of-his-depth-on-crypto-policy-polymarket-traders-just-cant-decide-on-a-favorite">industry and federal regulators.</a>
What Happened: Hoskinson <a href="https://x.com/IOHK_Charles/status/1859312190219862175">emphasized</a> the importance of the role being filled by someone &#8220;neutral&#8221; with a deep understanding of blockchain technology and the challenges posed by existing U.S. regulations.
"There is only one candidate that I think stands out in our industry for this role, and that's Brian Armstrong," Hoskinson wrote. 
He cited Armstrong's leadership at Coinbase, a company that has navigated significant regulatory hurdles, as a testament to his ability to unify the industry and drive meaningful policy reform.
A crypto position, <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42098407/donald-trump-reportedly-eyeing-the-first-crypto-focused-role-in-the-white-house">reportedly</a> being considered by President-elect Donald Trump's transition team, would mark the first time a White House role is dedicated exclusively to <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40001426/trump-aims-to-make-us-crypto-capital-of-the-planet-well-get-it-done">cryptocurrency policy</a>.
The position is expected to act as a bridge between the White House, Congress, and federal regulatory agencies, aiming to create a cohesive and supportive regulatory framework for digital assets.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42090657/microstrategy-upsizes-convertible-notes-offering-to-2-6-billion-for-bitcoin-purchases">MicroStrategy Upsizes Convertible Notes Offering To $2.6 Billion For Bitcoin Purchases</a>
Hoskinson's nomination of Armstrong comes as the blockchain industry anticipates major shifts under Trump's administration, which has promised a more <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41770352/bitcoins-future-under-president-elect-donald-trump-a-look-at-his-crypto-policies">crypto-friendly approach</a>.
Trump's campaign pledges included <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41680397/who-will-replace-gary-gensler-the-top-candidates-for-sec-chair-after-the-election">firing SEC Chair Gary Gensler</a>, scaling back regulatory oversight, and creating a presidential advisory council on cryptocurrency.
Hoskinson expressed his belief that Armstrong's experience would enable him to build a "broad tent coalition" to unite the fragmented crypto industry. 
He also announced his own efforts to support the policy framework, revealing plans to meet lawmakers in Washington, D.C., and launch an initiative called Operation Baseline. 
This project will survey the cryptocurrency industry to identify inefficiencies and propose actionable solutions for policymakers.
"The time has come to get this done so that we all can get back to work changing the world," Hoskinson said.
Armstrong, who recently endorsed Trump's newly announced Department of Government Efficiency, is no <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42084945/coinbase-ceo-brian-armstrong-backs-doge-initiative-how-blockchain-could-transform-government-efficiency">stranger to public policy debates. </a>
Armstrong described DOGE as a "once-in-a-lifetime opportunity" to streamline government operations, reduce waste, and enhance economic freedom. 
His vision aligns with blockchain's potential to improve transparency, reduce fraud, and simplify complex bureaucratic processes.
The creation of a crypto role could provide Armstrong with the platform to advocate for initiatives such as blockchain-driven transparency in government and Armstrong's own fiscal policy proposals, including a constitutional amendment to cap government spending.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42086650/robinhood-positioned-as-top-crypto-deregulation-trade-says-bernstein">Robinhood Positioned As Top &#8216;Crypto Deregulation&#8217; Trade, Says Bernstein</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$DOGE

COIN

Coinbase CEO Brian Armstrong 'Stands Out' As Candidate For Donald Trump's Reported 'Crypto Czar' Position, Cardano Co-Founder Says

Barclays analyst Seth Sigman maintains Williams-Sonoma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) with a Underweight and raises the price target from $116 to $123.

Barclays Maintains Underweight on Williams-Sonoma, Raises Price Target to $123

Oppenheimer analyst Leland Gershell reiterates argenx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) with a Outperform and raises the price target from $646 to $675.

ARGX

Oppenheimer Reiterates Outperform on argenx, Raises Price Target to $675

RBC Capital analyst Matthew Hedberg reiterates Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) with a Outperform and maintains $450 price target.

RBC Capital Reiterates Outperform on Palo Alto Networks, Maintains $450 Price Target

Offering Advertisers Enhanced Reach And Targeting Across Xumo Properties With PubMatic's Supply Path Optimization Capabilities

PUBM

Xumo Partners With PubMatic To Expand Programmatic Advertising

Oppenheimer analyst Ittai Kidron maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Outperform and maintains $180 price target.

Oppenheimer Maintains Outperform on Snowflake, Maintains $180 Price Target

<a href="https://www.capitoltrades.com/issuers/435690" title="https://www.capitoltrades.com/issuers/435690">https://www.capitoltrades.com/issuers/435690</a>

Politics

Trading Ideas

VSAT

Watcing ViaSat; Traders Circulate Representative Debbie Wasserman Schultz Has Bought Stock In The Company

Keurig Dr Pepper announces $60M secondary offering of common stock by JAB

The latest update is out from Keurig Dr Pepper ( ($KDP) ). Keurig Dr Pepper Inc. experienced a Board reshuffle as Lubomira Rochet resigned and Fran...

Keurig Dr Pepper Announces Board Reshuffle and Appointment

Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGS – VF Corp. (VFC) up 21.5% F5 Networks (FFIV...

Closing Bell Movers: VF Corp. surges after quarterly results

Morgan Stanley acted as sole book running manager for the offering. Published first on TheFly – the ultimate source for real-time, market-moving br...

Keurig Dr Pepper 60M share Spot Secondary priced at $32.85

JAB seeks to raise ~$1.97B with Keurig Dr Pepper share sale

Notable Top And Bottom S&P 500 Stocks In October 2024

What To Expect From October's 2024 Inflation Report

Keurig Dr Pepper (KDP) announced the appointment of Drew Panayiotou as Chief Marketing Officer or CMO , U.S. Refreshment Beverages, effective Novem...

Keurig Dr Pepper names Drew Panayiotou as CMO U.S. Refreshment Beverages

CPI read: Food prices ran below the overall inflation rate in October

Fidelity Select Consumer Staples Portfolio Q3 2024 Review

AAPL

AMZN

AVGO

BIVI

BRBR

BRFS

CALM

CDNS

CELH

COST

DLTR

FFIV

GOOG

GOOGL

INGR

JJSF

KVUE

LANC

MNST

MSFT

NVDA

POST

QRVO

REGN

SMCI

SMPL

TREX

TSLA

Press Releases

Keurig Dr Pepper Announces Multi-Year Sponsorship of the Men's and Women's Mexican National Teams in the U.S.

Black Rifle Coffee Company Announces Long-Term Sales and Distribution Agreement with Keurig Dr Pepper for Black Rifle Energy™ Drinks

Dividends

Keurig Dr Pepper Increases its Dividend by 7.0% and Declares Quarterly Dividend for Q3 2024

Keurig Dr Pepper to Report Third Quarter 2024 Results and Host Conference Call

Keurig Dr Pepper to Acquire Disruptive Energy Drink Business GHOST

Earnings

Keurig Dr Pepper Reports Q3 2024 Results and Reaffirms Fiscal 2024 Guidance

Offerings

Keurig Dr Pepper Announces Secondary Offering of Common Stock by JAB and Refreshed JAB Board Representation

Keurig Dr Pepper Announces Pricing of Secondary Offering of Common Stock by JAB

Keurig Dr Pepper Appoints Drew Panayiotou as Chief Marketing Officer, U.S. Refreshment Beverages

Keurig Dr Pepper to Participate in Morgan Stanley Global Consumer & Retail Conference

BRCC

Embotelladora Andina S.A. Common Stock

Celsius Holdings

The Vita Coco Company, Inc. - Common Stock

Vita Coco

Coca-Cola Consolidated, Inc. - Common Stock

Coca-Cola Consolidated

National Beverage

Fomento Economico Mexicano S.A.B. de C.V. Common Stock

Fomento Economico

Coca-Cola

Coca Cola Femsa S.A.B. de C.V. American Depositary Shares, each representing 10 Units (each Unit consists of 3 Series B Shares and 5 Series L Shares)

Comments

Keurig Dr Pepper

Notizie

Ultime notizie per Keurig Dr Pepper (NASDAQ:KDP) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO